![](/img/cover-not-exists.png)
Phase Ib study of pevonedistat, a NEDD8-activating enzyme inhibitor, in combination with docetaxel, carboplatin and paclitaxel, or gemcitabine, in patients with advanced solid tumors
Lockhart, A Craig, Bauer, Todd M., Aggarwal, Charu, Lee, Carrie B., Harvey, R Donald, Cohen, Roger B., Sedarati, Farhad, Nip, Tsz Keung, Faessel, Hélène, Dash, Ajeeta B., Dezube, Bruce J., Faller, DouLanguage:
english
Journal:
Investigational New Drugs
DOI:
10.1007/s10637-018-0610-0
Date:
May, 2018
File:
PDF, 555 KB
english, 2018